209 related articles for article (PubMed ID: 18572264)
1. Onset and progression of the Anderson-Fabry disease related cardiomyopathy.
Kampmann C; Linhart A; Baehner F; Palecek T; Wiethoff CM; Miebach E; Whybra C; Gal A; Bultas J; Beck M
Int J Cardiol; 2008 Nov; 130(3):367-73. PubMed ID: 18572264
[TBL] [Abstract][Full Text] [Related]
2. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
3. Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease.
Tomberli B; Cecchi F; Sciagrà R; Berti V; Lisi F; Torricelli F; Morrone A; Castelli G; Yacoub MH; Olivotto I
Eur J Heart Fail; 2013 Dec; 15(12):1363-73. PubMed ID: 23818648
[TBL] [Abstract][Full Text] [Related]
4. Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis.
Kampmann C; Linhart A; Devereux RB; Schiffmann R
Clin Ther; 2009 Sep; 31(9):1966-76. PubMed ID: 19843486
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease.
Zamorano J; Serra V; Pérez de Isla L; Feltes G; Calli A; Barbado FJ; Torras J; Hernandez S; Herrera J; Herrero JA; Pintos G
Eur J Echocardiogr; 2011 Sep; 12(9):671-7. PubMed ID: 21810826
[TBL] [Abstract][Full Text] [Related]
6. Normal left-atrial structure and function despite concentric left-ventricular remodelling in a cohort of patients with Anderson-Fabry disease.
Putko BN; Yogasundaram H; Chow K; Pagano J; Khan A; Paterson DI; Thompson RB; Oudit GY
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1129-36. PubMed ID: 25750198
[TBL] [Abstract][Full Text] [Related]
7. Cardiac manifestations of Anderson-Fabry disease in heterozygous females.
Kampmann C; Baehner F; Whybra C; Martin C; Wiethoff CM; Ries M; Gal A; Beck M
J Am Coll Cardiol; 2002 Nov; 40(9):1668-74. PubMed ID: 12427421
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease.
Monda E; Bakalakos A; Lachmann R; Syrris P; Limongelli G; Murphy E; Hughes D; Elliott PM
Heart; 2024 May; 110(12):846-853. PubMed ID: 38688703
[TBL] [Abstract][Full Text] [Related]
9. Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients.
Esposito R; Galderisi M; Santoro C; Imbriaco M; Riccio E; Maria Pellegrino A; Sorrentino R; Lembo M; Citro R; Angela Losi M; Spinelli L; Trimarco B; Pisani A
Eur Heart J Cardiovasc Imaging; 2019 Apr; 20(4):438-445. PubMed ID: 30085001
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women.
Faro DC; Losi V; Rodolico MS; Torrisi EM; Colomba P; Duro G; Monte IP
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761944
[TBL] [Abstract][Full Text] [Related]
11. Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy.
Gruner C; Verocai F; Carasso S; Vannan MA; Jamorski M; Clarke JT; Care M; Iwanochko RM; Rakowski H
Echocardiography; 2012 Aug; 29(7):810-7. PubMed ID: 22497597
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy.
Toro R; Perez-Isla L; Doxastaquis G; Barba MA; Gallego AR; Pintos G; Barbados FJ; Mangas A; Zamorano JL
Int J Cardiol; 2009 Feb; 132(1):38-44. PubMed ID: 18691784
[TBL] [Abstract][Full Text] [Related]
13. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.
Putko BN; Wen K; Thompson RB; Mullen J; Shanks M; Yogasundaram H; Sergi C; Oudit GY
Heart Fail Rev; 2015 Mar; 20(2):179-91. PubMed ID: 25030479
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey.
Elliott P; Baker R; Pasquale F; Quarta G; Ebrahim H; Mehta AB; Hughes DA;
Heart; 2011 Dec; 97(23):1957-60. PubMed ID: 21890869
[TBL] [Abstract][Full Text] [Related]
15. The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease.
Perry R; Shah R; Saiedi M; Patil S; Ganesan A; Linhart A; Selvanayagam JB
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1230-1242. PubMed ID: 31272606
[TBL] [Abstract][Full Text] [Related]
16. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.
Weidemann F; Breunig F; Beer M; Sandstede J; Störk S; Voelker W; Ertl G; Knoll A; Wanner C; Strotmann JM
Eur Heart J; 2005 Jun; 26(12):1221-7. PubMed ID: 15728649
[TBL] [Abstract][Full Text] [Related]
17. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.
Linhart A; Kampmann C; Zamorano JL; Sunder-Plassmann G; Beck M; Mehta A; Elliott PM;
Eur Heart J; 2007 May; 28(10):1228-35. PubMed ID: 17483538
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Clinical Evolution in Prehypertrophic Fabry Disease.
Camporeale A; Pieroni M; Pieruzzi F; Lusardi P; Pica S; Spada M; Mignani R; Burlina A; Bandera F; Guazzi M; Graziani F; Crea F; Greiser A; Boveri S; Ambrogi F; Lombardi M
Circ Cardiovasc Imaging; 2019 Apr; 12(4):e008424. PubMed ID: 30943767
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular hypertrophy in nondiabetic predialysis CKD.
Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
[TBL] [Abstract][Full Text] [Related]
20. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
